Review of prescribing information for influenza vaccines for pregnant and lactating women

Vaccine

Volumn 34, Issue 45, 2016, Pages 5406-5409

  Proveaux, Tina ^a   Lambach, Philipp ^b   Ortiz, Justin R ^b   Hombach, Joachim ^b   Halsey, Neal A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Influenza vaccine; Lactation; Pregnancy; Vaccine safety

Indexed keywords

INFLUENZA VACCINE;

BREAST FEEDING; DRUG INFORMATION; DRUG LABELING; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH RISK POPULATION; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H5N1); INFLUENZA VACCINATION; LACTATION; LANGUAGE; PANDEMIC INFLUENZA; PATIENT INFORMATION; PREGNANT WOMAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SEASONAL INFLUENZA; THIRD TRIMESTER PREGNANCY; FOOD AND DRUG ADMINISTRATION; INFLUENZA; PACKAGING; PREGNANCY; PREGNANCY COMPLICATION; PRODUCT SAFETY; PSYCHOLOGY; PUBLIC HEALTH SERVICE; STANDARDS; UNITED STATES; VACCINATION; WORLD HEALTH ORGANIZATION;

BREAST FEEDING; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CONSUMER PRODUCT SAFETY; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LACTATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANT WOMEN; PRODUCT LABELING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 84992645522     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.08.042     Document Type: Review

References (28)

1. [1] Centers for Disease Control and Prevention (CDC), Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices-United States, 2013–2014. MMWR Recomm Rep 62:RR-07 (2013), 1–43 [Sep 20].
2. [2] Public Health Agency of Canada. An advisory committee statement on seasonal influenza vaccine for 2015–2016. Modified 2016-03-08. Available online at: < http://www.phac-aspc.gc.ca/naci-ccni/assets/pdf/flu-2015-grippe-eng.pdf>; 2016 [last accessed 4 Aug 2016].
3. [3] Jackson, L.A., Patel, S.M., Swamy, G.K., Frey, S.E., Creech, C.B., Munoz, F.M., et al. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis 204:6 (2011), 854–863.
4. [4] World Health Organization, Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec 87 (2012), 461–476.
5. [5] Keller-Stanislawski, B., Englund, J.A., Kang, G., Mangtani, P., Neuzil, K., Nohynek, H., et al. Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 32 (2014), 7057–7064.
6. [6] WHO GACVS, Safety of immunization during pregnancy: a review of the evidence. Available online at , 2014 [last accessed 4 Aug 2016].
7. [7] Fell, D.B., Dodds, L., MacDonald, N.E., Allen, V.M., McNeil, S., Influenza vaccination and fetal and neonatal outcomes. Expert Rev Vaccines 12:12 (2013), 1417–1430.
8. [8] Bratton, K.N., Wardle, M.T., Orenstein, W.A., Omer, S.B., Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis. Clin Infect Dis 60:5 (2015), e11–e19.
9. [9] McMillan, M., Porritt, K., Kralik, D., Costi, L., Marshall, H., Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine 33:18 (2015), 2108–2117.
10. [10] Shimabukuro T. End-of-season update: 2014–2015 influenza vaccine safety monitoring. In: Presented at June 24, 2015 ACIP meeting.
11. [11] Wilson, R.J., Paterson, P., Jarrett, C., Larson, H.J., Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine 33 (2015), 6420–6429.
12. [12] McCarthy, E.A., Pollock, W.E., Nolan, T., Hay, S., McDonald, S., Improving influenza vaccination coverage in pregnancy in Melbourne 2010–2011. Aust NZ J Obstet Gynaecol 52 (2012), 334–341.
13. [13] Gruber, M.F., Global and national initiatives to facilitate studies of vaccines in pregnant women. Clin Infect Dis 59:Suppl. 7 (2014), S395–S399.
14. [14] Bednarczyk, R.A., Adjaye-Gbewonyo, D., Omer, S.B., Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol 207:3 Suppl. (2012), S38–S46.
15. [15] Verweij, M., Lambach, P., Ortiz, J.R., Reis, A., Maternal immunization: ethical issues. Lancet Infect Dis, 2016 (in print).
16. [16] Nieminen, O., Kurki, P., Nordström, K., Differences in product information of biopharmaceuticals in the EU and the USA: implications for product development. Eur J Pharm Biopharm 60:3 (2005), 319–326.
17. [17] Halsey, N.A., Talaat, K.R., Greenbaum, A., Mensah, E., Dudley, M.Z., Proveaux, T., et al. The safety of influenza vaccines in children: an Institute for Vaccine Safety white paper. Vaccine 33:Suppl. 5 (2015), F1–F67.
18. [18] Gruber, M.F., The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization. Vaccine 33 (2015), 6499–6500.
19. [19] European Medicines Agency. Committee for medicinal products for human use (CHMP). Guideline on risk assessment of medicinal products on human reproduction and lactation: from data to labelling, 24 July 2008. Available online at < http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003307.pdf>; 2008 [last accessed 4 Aug 2016].
20. [20] Lester, R.T., McGeer, A., Tomlinson, G., Detsky, A.S., Use of, effectiveness of, and attitudes regarding influenza vaccine among house staff. Infection control and hospital epidemiology. Infect Control Hosp Epidemiol 24 (2003), 839–844.
21. [21] Weingarten, S., Riedinger, M., Bolton, L.B., Miles, P., Ault, M., Barriers to influenza vaccine acceptance. A survey of physicians and nurses. Am J Infect Control 17 (1989), 202–207.
22. [22] Hofmann, F., Ferracin, C., Marsh, G., Dumas, R., Influenza vaccination of healthcare workers: a literature review of attitudes and beliefs. Infection 34 (2006), 142–147.
23. [23] Kimmel, S.R., Puczynski, S., McCoy, R.C., Puczynski, M.S., Practices of family physicians and pediatricians in administering poliovirus vaccine. J Fam Pract 48 (1999), 594–600.
24. [24] Yuen, C.Y., Tarrant, M., Determinants of uptake of influenza vaccination among pregnant women – a systematic review. Vaccine 32:36 (2014), 4602–4613.
25. [25] Blanchard-Rohner, G., Siegrist, C.A., Vaccination during pregnancy to protect infants against influenza: why and why not?. Vaccine 29 (2011), 7542–7550.
26. [26] Brydak, L.B., Nitsch-Osuch, A., Vaccination against influenza in pregnant women. Acta Biochim Pol 61 (2014), 589–591.
27. [27] World Health Organization. Executive summary: WHO working group meeting on labelling information of influenza vaccines intended to be used in pregnant women, 24–25 Sep 2015, Geneva, Switzerland. Available online at < http://www.who.int/biologicals/areas/vaccines/Executive_summary_FINAL_labelling_Sept_mtg_16_Dec_2015.pdf>; 2015 [last accessed 4 Aug 2016].
28. [28] Savitz, D.A., Fell, D.B., Ortiz, J.R., Bhat, N., Does influenza vaccination improve pregnancy outcome? Methodological issues and research needs. Vaccine 33:47 (2015), 6430–6435.